CONMED Stock (NYSE:CNMD)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$72.24

52W Range

$61.05 - $117.27

50D Avg

$69.39

200D Avg

$72.21

Market Cap

$2.31B

Avg Vol (3M)

$408.79K

Beta

1.46

Div Yield

$0.80 (1.07%)

CNMD Company Profile


CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,000

IPO Date

Jul 23, 1987

Website

CNMD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22
Orthopedic Surgery$533.16M$461.53M
General Surgery$711.59M$583.94M

Fiscal year ends in Dec 23 | Currency in USD

CNMD Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.24B$1.05B$1.01B
Operating Income$137.22M$70.05M$37.85M
Net Income$64.46M$-80.58M$62.54M
EBITDA$209.09M$-41.96M$108.59M
Basic EPS$2.04$-2.50$2.14
Diluted EPS$2.04$-2.50$1.94

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 9:21 PM
Q2 24Jul 31, 24 | 10:33 PM
Q1 24Apr 24, 24 | 12:00 AM

Peer Comparison


TickerCompany
ATECAlphatec Holdings, Inc.
ANIKAnika Therapeutics, Inc.
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
SRDXSurmodics, Inc.
LIVNLivaNova PLC
IRTCiRhythm Technologies, Inc.
STESTERIS plc
KIDSOrthoPediatrics Corp.
SIBNSI-BONE, Inc.
GKOSGlaukos Corporation
GMEDGlobus Medical, Inc.